UTI Healthcare Fund - IDCW Payout Plan
UTI Asset Management Co Ltd
₹251.40 (+0.51%)
NAV as of 9 Oct 2026
Minimum Investment: ₹5,000
Return
12.09% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 2.26%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹5,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,175
Invested ₹1,000
▲+17.51%1 year
₹1,121
Invested ₹1,000
▲+12.09%3 years
₹1,212
Invested ₹1,000
▲+21.17%5 years
₹1,138
Invested ₹1,000
▲+13.81%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +12.09% | +21.17% | +13.81% | — |
| Cumulative returns (%) | +12.09% | +77.91% | +90.91% | +247.49% |
Fund Manager
| Manager | Kamal Gada |
|---|---|
| Role | Manager |
| Manager Tenure | 4.42 yrs |
About Fund
| Date of Incorporation | 28 Jun 1999 |
|---|---|
| Fund House | UTI Asset Management Co Ltd |
| Custodian | Stock Holding Corporation of India |
| Registrar / Transfer Agent | UTI Asset Management Co Ltd |
| Address | Mittal Court, ‘B’ Wing,,Nariman Point |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 7.62% |
| Divi's Laboratories Ltd | 6.15% |
| Dr Reddy's Laboratories Ltd | 5.24% |
| Ajanta Pharma Ltd | 4.81% |
| Gland Pharma Ltd | 4.06% |
| Alkem Laboratories Ltd | 3.70% |
| Cipla Ltd | 3.43% |
| Glenmark Pharmaceuticals Ltd | 3.35% |
| Max Healthcare Institute Ltd Ordinary Shares | 3.10% |
| Fortis Healthcare Ltd | 3.05% |
| Apollo Hospitals Enterprise Ltd | 3.03% |
| Caplin Point Laboratories Ltd | 3.02% |
| Procter & Gamble Health Ltd | 3.02% |
| Global Health Ltd | 2.96% |
| Jupiter Life Line Hospitals Ltd | 2.91% |
| Lupin Ltd | 2.89% |
Investment Strategy
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Long term capital appreciation
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.